Foracort Rotacaps 200
$150.00 – $414.00Price range: $150.00 through $414.00
SKU : N/A
Category : Inhaler & Respules
Foracort Rotacaps 200 are inhalation capsules combining budesonide and formoterol used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD) to help reduce airway inflammation and improve breathing. They’re intended for regular preventive therapy with a rotahaler device and not for sudden relief of acute symptoms.
Foracort Rotacaps 200
Foracort Rotacaps 200 is a combination respiratory treatment widely prescribed for the maintenance of chronic airway diseases, particularly asthma and chronic obstructive pulmonary disease (COPD). These rotacaps are formulated to be inhaled using a Rotahaler (or similar capsule inhalation device), delivering medication directly into the lungs where it can act effectively to reduce inflammation and improve airflow.
Composition and Mechanism of Action
Each Foracort Rotacap contains two active ingredients:
-
Budesonide (200): An inhaled corticosteroid (ICS) that reduces inflammation and swelling in the airways. Inflammation is a central feature of asthma and COPD that leads to persistent symptoms like wheezing, chest tightness, and coughing. Budesonide suppresses the release and activity of inflammatory mediators, helping to decrease airway irritation over time.
-
Formoterol (6): A long-acting beta-2 agonist (LABA) bronchodilator that relaxes the smooth muscle surrounding the airways, allowing them to widen and improve airflow. This action helps ease symptoms such as breathlessness and wheezing.
The combination of an anti-inflammatory agent with a bronchodilator makes Foracort Rotacaps 200 an effective maintenance therapy, addressing both the underlying airway inflammation and the functional airway narrowing seen in chronic respiratory diseases.
Primary Uses and Benefits
Foracort Rotacaps 200 are primarily prescribed for:
-
Asthma maintenance therapy: Long-term management of persistent asthma symptoms. By regularly reducing airway inflammation and keeping airways relaxed, it helps prevent symptom flare-ups and improve overall control of asthma.
-
Chronic Obstructive Pulmonary Disease (COPD): Management of moderate to severe COPD symptoms, such as breathlessness, chronic cough, and wheezing. The medication helps increase airflow and support better day-to-day lung function.
When used consistently and as prescribed, Foracort Rotacaps 200 can:
-
Improve breathing comfort and lung function
-
Reduce the frequency and severity of symptoms
-
Lower the risk of exacerbations and hospital visits
-
Enhance quality of life by supporting day-to-day respiratory health
It’s important to note that Foracort Rotacaps are preventive therapy and are not intended to treat sudden episodes of breathlessness. For acute relief, patients should have a separate short-acting “rescue” inhaler (e.g., salbutamol).
How to Use Foracort Rotacaps 200
Foracort Rotacaps are inhalable capsules and should not be swallowed. They must be used with a Rotahaler or equivalent device that pierces the capsule and allows the medication to be inhaled deeply into the lungs.
Typical steps include:
-
Place one capsule into the Rotahaler.
-
Twist the mouthpiece assembly until you hear a click, which crushes the capsule.
-
Exhale fully away from the device.
-
Seal your lips around the mouthpiece and inhale deeply and steadily to draw the medication into your lungs.
-
Hold your breath for a few seconds to allow the medicine to settle in the airways.
-
Discard the empty capsule shell.
-
Rinse your mouth with water and spit after inhalation to help reduce the risk of oral fungal infection (thrush).
Your healthcare provider will instruct you on the correct dosing frequency, which is typically twice daily (morning and evening) for maintenance therapy, unless otherwise directed.
Side Effects and Precautions
Foracort Rotacaps 200 may cause side effects in some individuals. Common reactions include:
-
Headache
-
Nausea and vomiting
-
Cough or hoarse voice
-
Throat irritation or sore throat
-
Fungal infections in the mouth or throat (oral candidiasis)
-
Palpitations or tremors
-
Upper respiratory tract infections
If symptoms are severe, persistent, or concerning (e.g., white patches in the mouth, difficulty breathing), contact your doctor promptly.
Before starting Foracort Rotacaps, patients should inform their healthcare provider about any existing conditions such as heart disease, high blood pressure, diabetes, thyroid disorders, glaucoma, or osteoporosis, as these may influence treatment decisions or monitoring.
External Resource for More Information
For further medically reviewed information on combination inhalers like budesonide and formoterol in asthma and COPD management, visit this comprehensive guide from WebMD: https://www.webmd.com/asthma/guide/asthma-inhalers-overview.
| Pack Size |
180 Piece ,60 Piece ,90 Piece |
|---|
Related products
Aerocort Rotacaps
Aerocort Rotacaps containing Beclomethasone Dipropionate is a prescription inhalation medicine for asthma and COPD, designed to improve breathing under medical supervision.
Asthalin Rotacaps 200 mg
Budesonide 1 Respules
Budesonide 200 Rotacaps
Foracort Rotacaps 100 mcg
Foracort Rotacaps 100 mcg is a combination inhalation therapy containing budesonide and formoterol used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD), helping reduce airway inflammation and improve airflow. It is designed for regular daily use with a rotahaler and not for immediate relief of sudden breathing attacks.
Furamist Nasal Spray 27.5 mcg
Furamist Nasal Spray 27.5 mcg is a corticosteroid nasal spray containing fluticasone furoate used to relieve symptoms of allergic rhinitis such as sneezing, runny or itchy nose, and nasal congestion. It works by reducing inflammation in the nasal passages and should be used regularly as directed by a healthcare provider for best results.
Levolin synchro breathe Inhaler
Levolin Synchro Breathe Inhaler, containing Levolin synchro breathe Inhaler, is a physician-supervised bronchodilator used to relieve asthma and COPD-related breathing difficulties.

